In addition to various biological activities, interferon-γ (IFN-γ) inhibits bone resorption and collagen synthesis. We produced a transgenic mouse line expressing the murine IFN-γ gene and protein in the bone marrow and thymus. Forty-five transgenic FVB/NCr mice, 23 days-9 months of age, were studied for anomalies in the skeletal system. The transgenic mice had short, wide, and deformed long bones. Young transgenic mice had epiphyseal plates severely thickened with zones of hypertrophy and degeneration with irregular metaphyseal borders. Cartilagenous masses were also observed in the metadiaphyseal marrow cavities. These lesions were primarily seen in long bones and ribs. Adult transgenic mice had residues of degenerated cartilagenous masses in the diaphyses. Many osteoclasts with well-developed ruffled borders were present on the metaphyseal cartilagenous masses in young transgenic mice. Adult transgenic mice had less prominent primary spongiosa with fewer osteoclasts at the metaphysis as compared with nontransgenic controls. The cortical bones of the transgenic mice were thinner and more immature compared with controls. Transgenic mice also had fractures, disruption of the epiphyseal plate, and degeneration of articular cartilage. Thus, the IFN-γ transgenic mice developed a complex chondro-osseous lesion that was diagnosed as osteochondrodysplasia. The lesions may originate from primarily decreased matrix synthesis in bone and cartilage and also possible osteoclast-related changes caused by IFN-γ overexpression in the bone marrow. Our IFN-γ transgenic mouse will be a useful model to investigate the role of IFN-γ in bone metabolism.
BonadioJSaundersTLTsaiEGoldsteinSAMorris-WimanJBrinkleyLDolanDAltschulerRAHawkinsJEJrBatemanJFMascaraTJaenischR:
Transgenic mouse model of the mild dominant form of osteogenesis imperfecta.
Proc Natl Acad Sci USA87:7145–7149, 1990
5.
CentrellaMMcCarthyTLCanalisE:
Growth factors and cytokines. In:
Bone, Volume 3, Bone Metabolism and Mineralization,
ed. HallBK,
pp. 47–72.
CRC Press, Boca Raton, FL,
1992
6.
CherayilBJWeinerSJPillaiS:
The Mac-2 antigen is a galactose-specific lectin that binds IgE.
J Exp Med170:1959–1972, 1989
7.
ChipmanSTSweetHOMcBrideDJJrDavissonMTMarksSCJrShuldinerARWenstrupRJRoweDWShapiroJR:
Defective proα2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta.
Proc Natl Acad Sci USA90:1701–1705, 1993
8.
ColeWG:
Osteogenesis imperfecta as a consequence of naturally occurring and induced mutations of type I collagen. In:
Bone and Mineral Research/8,
ed. HeerscheJNMKanisJA,
pp. 167–204.
Elsevier Science BV, Amsterdam, The Netherlands,
1994
9.
EgwuaguCESzteinJSChanC-CReidWMahdiRNussenblattRBChepelinskyAB:
Ectopic expression of gamma interferon in the eyes of transgenic mice induces ocular pathology and MHC class II gene expression.
Invest Ophthalmol Vis Sci35:332–341, 1994
10.
FujiiYSatoKKosanoKSatohTFujiiTShizumeK:
Prolonged and ubiquitous inhibition by interferon γ of bone resorption induced by parathyroid hormone-related protein, 1,25-dihydroxyvitamin D3, and interleukin 1 in fetal mouse forearm bones.
Calcif Tissue Int47:178–182, 1990
11.
GarofaloSVuorioEMetsarantaMRosatiRTomanDVaughanJLozanoGMayneREllardJHortonWde CrombruggheB:
Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen α1-chain gene.
Proc Natl Acad Sci USA88:9648–9652, 1991
12.
Gehron RobeyPTermineJD:
Biochemical markers of metabolic bone disease. In:
Metabolic Bone Disease and Clinically Related Disorders,
ed. AvioliLVKraneSM,
2nd ed., pp. 244–263.
WB Saunders, Philadelphia, PA,
1990
13.
GolderingMBGolderingS:
Skeletal tissue response to cytokines.
Clin Orthop258:245–278, 1990
14.
GoldringMBSandellLJStephensonMLKraneSM:
Immune interferon suppresses levels of procollagen mRNA and type II collagen synthesis in cultured human articular and costal chondrocytes.
J Biol Chem261:9049–9056, 1986
15.
GowenMNedwinGEMundyGR:
Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gamma.
J Bone Min Res1:469–474, 1986
16.
GransteinRDMurphyGFMargolisRJByrneMHAmentoEP:
Gamma-interferon inhibits collagen synthesis in vivo in the mouse.
J Clin Invest79:1254–1258, 1987
17.
HoffmannOKlaushoferKGleispachHLeisHJLugerTKollerKPeterlikM:
Gamma interferon inhibits basal and interleukin 1-induced prostaglandin production and bone resorption in neonatal mouse calvaria.
Biochem Biophys Res Commun143:38–43, 1987
18.
IjzermansJNMMarquetRL:
Interferon-gamma: a review.
Immunobiol179:456–473, 1989
JonssonRTarkowskiAKlareskogL:
A demineralization procedure for immunohistopathological use: EDTA treatment preserves lymphoid cell surface antigens.
J Immunol Meth88:109–114, 1986
21.
KuivaniemiHTrompGProckopDJ:
Mutations in collagen genes: causes of rare and some common diseases in humans.
FASEB J5:2052–2060, 1991
22.
LewisDBLiggittHDEffmannELMotleyTMTeitelbaumSLJepsenKJGoldsteinSABonadioJCarpenterJPerlmutterRM:
Osteoporosis induced in mice by overproduction of interleukin 4.
Proc Natl Acad Sci USA90:11618–11622, 1993
23.
MarksSCJrPopoffS:
Bone cell biology: the regulation of development, structure, and function in the skeleton.
Am J Anat183:1–44, 1988
24.
MinkinC:
Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function.
Calcif Tiss Int34:285–290, 1982
25.
MundyGR:
Cytokines of bone. In:
Physiology and Pharmacology of Bone. Handbook of Experimental Pharmacology,
ed. MundyGRMartinTJ,
pp. 185–214.
Springer, New York, NY,
1993
26.
NiidaSAmizukaNHaraFOzawaHKodamaH:
Expression of Mac-2 antigen in the preosteoclast and osteoclast identified in the op/op mouse injected with macrophage colony-stimulating factor.
J Bone Min Res9:873–881, 1994
27.
PereiraRKhillanJSHelminenHJHumeELProckopDJ:
Transgenic mice expressing a partially deleted gene for type I procollagen (COL1A1): a breeding line with a phenotype of spontaneous fractures and decreased bone collagen and mineral.
J Clin Invest91:709–716, 1993
28.
PeterlikMHoffmannOSwetlyPKlaushoferKKollerK:
Recombinant γ-interferon inhibits prostaglandin-mediated and parathyroid hormone-induced bone resorption in cultured neonatal mouse calvaria.
FEBS Lett185:287–290, 1985
29.
RimoinDLLachmanRS:
The chondrodysplasias. In:
Principles and Practice of Medical Genetics,
vol. 2,
ed. EmeryAEHRimoinDL,
pp. 703–735.
Churchill Livingstone, London, UK,
1983
30.
RoweDW:
Osteogenesis imperfecta. In:
Bone and Mineral Research/7,
ed. HeerscheJNMKanisJA,
pp. 209–241.
Elsevier Science Publishers BV, Amsterdam, The Netherlands,
1990
31.
RoweDWShapiroJR:
Osteogenesis imperfecta. In:
Metabolic Bone Disease and Clinically Related Disorders,
ed. AvioliLVKraneSM,
2nd ed., pp. 659–701.
WB Saunders, Philadelphia, PA,
1990
32.
SarvetnickNLiggittDPittsSLHansenSEStewartTA:
Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma.
Cell52:773–782, 1988
33.
SatoKSatohTShizumeKYamakawaYOnoYDemuraHAkatsuTTakahashiNSudaT:
Prolonged decrease of serum calcium concentration by murine γ-interferon in hypercalcemic, human tumor (EC-GI)-bearing nude mice.
Cancer Res52:444–449, 1992
SmithDDGowenMMundyGR:
Effect of interferon-γ and other cytokines on collagen synthesis in fetal rat bone cultures.
Endocrinology120:2494–2499, 1987
36.
StacyABatemanJChoiTMascaraTColeWJaenischR:
Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-α1(I) collagen gene.
Nature332:131–136, 1988
37.
StephensonMLKraneSMAmentoEPMcMroskeryPAByrneM:
Immune interferon inhibits collagen synthesis by rheumatoid synovial cells and associated with decreased levels of the procollagen mRNAs.
FEBS Lett180:43–50, 1985
38.
TakahashiNMundyGRoodmanGD:
Recombinant human interferon-γ inhibits formation of human osteoclast-like cells.
J Immunol137:3544–3549, 1986
39.
ThomasJTAyadSGrantME:
Cartilage collagens: strategies for the study of their organization and expression in the extracellular matrix.
Ann Rheumat Dis53:488–496, 1994
40.
TilstraDJByersPH:
Molecular basis of hereditary disorders of connective tissue.
Annu Rev Med45:149–163, 1994
41.
ToyonagaTHinoOSugaiSWakasugiSAbeKShichiriMYamamuraK:
Chronic active hepatitis in transgenic mice expressing interferon-γ in the liver.
Proc Natl Acad Sci USA91:614–618, 1994
42.
TrinchieriGPerussiaB:
Immune interferon: a pleiotropic lymphokine with multiple effects.
Immunol Today6:131–136, 1985
43.
VandenbergPKhillanJSProckopDJHelminenHKontusaariSAla-KokkoL:
Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasia.
Proc Natl Acad Sci USA88:7640–7644, 1991
44.
van der RestM:
The collagens of bone. In:
Bone, Volume 3, Bone Matrix and Bone Specific Products,
ed. HallBK
pp. 187–237.
CRC Press, Boca Raton, FL,
1991
45.
VikkulaMMetsärantaMAla-KokkoL:
Type II collagen mutations in rare and common cartilage diseases.
Ann Med26:107–114, 1994
46.
WatanabeKTanakaYMorimotoIYahataKZekiKFujihiraTYamashitaUEtoS:
Interleukin-4 as a potent inhibitor of bone resorption.
Biochem Biophys Res Commun172:1035–1041, 1990
47.
YoungHAKlinmanDMReynoldsDAGrzegorzewskiKJNiiAWardJMWinkler-PickettRTOrtaldoJRKennyJJKomschliesKL:
Bone marrow and thymus expression of interferon-γ results in severe B-cell lineage reduction, T-cell lineage alterations and hematopoietic progenitor deficiencies.
Blood89:583–595, 1997
